This data indicates the positive role of p53/p21 complex in sensitizing wild-type p53 HCT 116 cells to OX and the lack of functionality of this complex formation in mutant p53 HT 29 colon cancer cells makes them less sensitivity to OX treatment. This evidence concerns the gene TP53 and malignant colon neoplasm.